Clipping of news on Brazilian Culture, Law and Citizenship
03/07/2012
This article was translated by an automatic translation system, and was therefore not reviewed by people.
Tenofovir is an antiretroviral already used in tablets and vaginal gel.
Unprotected anal sex is 20 times greater risk of transmission.
A gel against HIV designed to be used in the rectum was considered safe and acceptable after an initial testing phase. The product still needs to go through two stages of more comprehensive testing before being launched.
Tenofovir is an antiretroviral which is already used AIDS in the form of tablets or vaginal gel. The microbicide, as it is called the gel used in this way, is one of the medical approaches to reduce HIV transmission through sex.
The product being tested is a version of the vaginal gel with less glycerin, which makes it more suited to the rectum. Without protection, the risk of HIV transmission through anal sex is 20 times higher than by vaginal sex.
The study included 65 men and women in three different locations in the U.S.. Some used the gel and other products used as a basis of comparison. Only 18% of participants had significant side effects, and 87% of students who used the product said they would return to use it in the future.
"The results show that the adapted version of the rectum of tenofovir was much better tolerated than vaginal formula, when used in the rectum," concluded Ian McGowan, University of Pittsburgh, one of those responsible for clinical study.
Source: MSN News
Our news are taken in full of our partner sites. For this reason, we can not change the content of these up in case of typing errors.
This article was translated by an automatic translation system, and was therefore not reviewed by people.